APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 200 MG
EMTRICITABINE : 200 MG EFAVIRENZ : 600 MG TENOFOVIR DISOPROXIL FUMARATE : 300 MG · DIN 02468247 · APOTEX INC
Health Canada status: MARKETED
What is APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR?
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 200 MG contains EMTRICITABINE : 200 MG EFAVIRENZ : 600 MG TENOFOVIR DISOPROXIL FUMARATE : 300 MG. It is listed in the Health Canada Drug Product Database under DIN 02468247, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 04-Sep-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR used for?
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR (efavirenz [EFV]/emtricitabine [FTC]/tenofovir disoproxil fumarate [TDF]) is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02468247 |
|---|---|
| Brand name | APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR |
| Generic / active ingredient | EMTRICITABINE : 200 MG EFAVIRENZ : 600 MG TENOFOVIR DISOPROXIL FUMARATE : 300 MG |
| Manufacturer | APOTEX INC |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J05AR06 EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ |
| AHFS class | 08:18.08.20 ; 08:18.08.16 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 04-Sep-2018 |
| Original market date | 2018-09-04 00:00:00 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code J05AR06 EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ. 5 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 200 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02478404 |
| JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 300 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02519461 |
| MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 300 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED | DIN 02461412 |
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 200 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02393549 |
| ATRIPLA | 200 MG | TABLET | GILEAD SCIENCES, LLC | CANCELLED POST MARKET | DIN 02300699 |
| PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 600 MG | TABLET | PHARMASCIENCE INC | DORMANT | DIN 02487284 |
| RIVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300 MG | TABLET | LABORATOIRE RIVA INC. | CANCELLED POST MARKET | DIN 02518716 |
| SANDOZ EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 200 MG | TABLET | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02484676 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.